Archive · 11 Dec 2025
Vets Test Ozempic-Inspired Weight-Loss Drug on Cats
Doctors for cats are testing a new medicine called OKV-119 to help chubby cats lose weight.
This medicine is like the one humans take called Ozempic.
It's a small implant that goes under the cat's skin and slowly gives the medicine over six months.
More than half of all pet cats in the world are too heavy, which can make them sick.
This new medicine might help cats feel better and live longer by making their bodies use energy better and not be so hungry.
It's easier than making cats go on a diet because the implant does the work without changing their eating habits too much.
OKAVA Pharmaceuticals is testing OKV-119, a weight-loss drug for cats, inspired by human drug Ozempic.
The drug is delivered via a subcutaneous implant that releases medication over six months.
Over 50% of pet cats worldwide are estimated to be overweight or obese.
OKV-119 aims to improve insulin sensitivity, reduce fat mass, and enhance energy metabolism in cats.
The drug works as a GLP-1 receptor agonist, similar to human weight-loss drugs like Ozempic and Wegovy.
- Who
- OKAVA Pharmaceuticals and veterinarians
- What
- Testing a weight-loss drug (OKV-119) for overweight cats
- When
- Currently underway (specific timeline not mentioned)
- Where
- Not specified (clinical trial location not mentioned)
- Why
- To address feline obesity and related health issues
- Drug Name
- OKV-119
- Company
- OKAVA Pharmaceuticals
- Drug Type
- GLP-1 receptor agonist
- Delivery Method
- Subcutaneous implant
- Duration
- 6 months
- Target Condition
- Feline obesity
- Global Obesity Rate in Cats
- More than 50%